I have been engaged in the study of inflammatory bowel disease (IBD) for four decades and have been treating patients with IBD during this time. My research interests span clinical, basic and translational research and are primarily focused on immunopathologic mechanisms, discovery of novel therapeutics and the translation of basic science and genetic findings for use in diagnosis, prognosis and targeted therapeutic selection in IBD. My goal is to combine all of these areas so that the right patient gets the right treatment at the right time and in the right way."
Learn more about the scientists, faculty members, investigators and other healthcare professionals of the Targan Laboratory, whose dedicated efforts lead to groundbreaking discoveries.
Gonsky R, Fleshner P, Deem RL, Biener-Ramanujan E, Li D, Potdar AA, Bilsborough J, Yang S, McGovern DPB, Targan SR.
Gastroenterology. 2017 Jul;153(1):219-232.
Zhang H, Zheng L, McGovern DP, Hamill AM, Ichikawa R, Kanazawa Y, Luu J, Kumagai K, Cilluffo M, Fukata M, Targan SR, et al.
J Immunol. 2017 Mar 1;198(5):2133-2146.
Thomas LS, Targan SR, Tsuda M, Yu QT, Salumbides BC, Haritunians T, Mengesha E, McGovern DP, Michelsen KS.
J Leukoc Biol. 2017 Mar;101(3):727-737.